CHELMSFORD, Mass., July 11, 2023 (Newswire.com) - AMD Global Telemedicine Inc. (AMD), a renowned global leader in telemedicine technology solutions, is thrilled to announce a strategic partnership with Collain Healthcare, a leading electronic health records and data management provider. This collaboration brings forth a powerful combined vitals collection and Electronic Health Records (EHR) solution that revolutionizes healthcare delivery in senior living facilities, providing real-time information, reducing errors, and streamlining clinical workflows.

In light of the extreme staffing challenges currently facing senior living facilities, seamless integration of technology is crucial for reducing the burden on clinical staff and optimizing patient care. By combining the strengths of AMD Global Telemedicine's cutting-edge automated vitals collection system with Collain Healthcare's advanced EHR software, healthcare providers gain access to a unified solution that streamlines and accelerates clinical workflows, enhances communication, and improves patient outcomes.

The integration partnership between AMD Global Telemedicine and Collain Healthcare capitalizes on the strengths and expertise of both organizations. Integrating automated vitals collection with the EHR is the first phase of the partnership. Both companies have plans to develop further integrations for virtual care visits and telehealth programs.

"We are excited to partner with Collain Healthcare to deliver an unmatched, combined EHR and automated vitals collection solution to skilled nursing and other senior living facilities," said Eric Bacon, President at AMD Global Telemedicine. "This partnership represents a significant step forward in our mission to transform healthcare delivery. Through this and future integrations that leverage the strengths of both organizations, we are poised to revolutionize the way healthcare is delivered and empower medical professionals to provide exceptional patient care."

"At Collain Healthcare, we are committed to improving healthcare outcomes through innovative technology solutions," said Charles Hehn, VP of Operations at Collain Healthcare. "By integrating our EHR software with AMD Global Telemedicine's technology solutions, we provide healthcare providers with a comprehensive toolset that enhances clinical workflows, increases efficiency, and ultimately delivers better patient care."

About AMD Global Telemedicine:

AMD Global Telemedicine is a leading provider of telemedicine technology solutions, dedicated to transforming healthcare delivery worldwide. With a commitment to customer needs, AMD Global Telemedicine develops advanced platforms and software that connect medical professionals with patients across the globe. By delivering high-quality clinical telehealth solutions, AMD Global Telemedicine empowers healthcare organizations to provide exceptional care to patients, regardless of their geographical locations. Visit www.amdtelemedicine.com for more information.

About Collain Healthcare

Collain Healthcare is a recognized leader in healthcare software solutions, delivering comprehensive EHR systems designed to streamline clinical workflows and improve patient outcomes. At Collain, we believe that electronic health records should be accessible, intuitive, and easy to use. Our bold and innovative solutions reduce paper-based processes, reduce staff time spent on documentation, and increase staff satisfaction. Collain's cloud-based platform allows for anytime, anywhere access and enables streamlined documentation processes, improved documentation accuracy, and better care coordination.

Contact Information:
Keri Souza
VP of Marketing
[email protected]
978-937-9021


Original Source: AMD Global Telemedicine and Collain Healthcare Announce Strategic Partnership to Revolutionize Healthcare Delivery in Senior Living Facilities

NEW YORK, July 11, 2023 (Newswire.com) - Somatix leadership presented the results of its brand-new medication compliance and hydration capabilities that were trained and launched in Portuguese hospitals and clinics as part of the Building Tomorrow Together - Innovation in Dementia Program with Roche Pharmaceuticals, Multicare, and Beta-i Collaborative Innovation. The project was part of an open innovation initiative powered by Beta-i, in which four startups, including Somatix, were selected to conduct their pilots in public or private institutions in Portugal. Somatix is honored to be part of this project to improve the quality of life of patients with dementia.

Using its unique artificial intelligence-enabled technology, Somatix is able to provide powerful clinical insights from wearables worn by patients with early to mid-stage dementia, including hydration, falls and medication compliance. Dehydration and missed medication dosages are potentially preventable events that otherwise lead to injury and illness. With the combination of remote monitoring, telehealth, and Somatix's SafeBeing^TM platform, the goal is to keep these patients safer and healthier while preserving their independence, and to improve their quality of life either at home or in an independent living facility. Partnering with Roche and two major health providers in Portugal, Campus Neurologico Senior (cnscampus.com) and CUF (cuf.pt), Somatix demonstrated the first successful clinical use of its ground-breaking medication compliance feature.

Dr. Charles Herman, CEO of Somatix, commented, "Somatix's AI-powered Remote Patient Monitoring (RPM) platform for healthcare providers uniquely uses wearable-enabled gesture detection to yield powerful clinical insights to improve patient outcomes with the help of strategic partners like Roche and Multicare, our sponsors; CNS and CUF, our healthcare provider partners; and Beta-i, the open innovation program developer; bringing groundbreaking technology to the aging population in Europe. We also worked closely with our ecosystem partner, Amazon Web Services, to build our first cloud-based server in Europe."

"Somatix is happy to report that the medication compliance feature was accurately able to detect pills taken and missed with over 70% accuracy. Based on the experience with Roche and its partners, we have already found opportunities to further improve the accuracy of our medication intake algorithm and plan to reach close to 90% accuracy in the next phase of our project. We also observed close to 95% accuracy in detecting the amount of fluid consumed over a day," says Dr. Amit Sawant, COO of Somatix.

Somatix and Roche plan to expand the partnership later this year, bringing Somatix's platform to more outpatients with early and mid-stage dementia in an effort to keep them safer and healthier in their own environments.

Contact Information:
Jessica Bradley
Director of Sales
[email protected]


Original Source: Somatix and Roche Launch an Only-of-Its-Kind Medication Compliance Capability Using AI-Enabled Wearable Technology

Innovative Tech Utilizes AI/ML, IoT/BLE Devices, and Digital Whiteboards

ATLANTA, July 11, 2023 (Newswire.com) - Vizzia Technologies, a leading software and managed service provider of real-time location systems (RTLS) for healthcare organizations, has announced several new technology partnerships to expand its portfolio of digital solutions for smart, connected hospitals.

"Vizzia is proud to collaborate with these world-class technology leaders," said Dave Wiedman, Chief Commercial Officer of Vizzia Technologies. "We are committed to delivering innovative solutions that improve healthcare efficiency and patient care."

New Technology Partners:

* Zebra Technologies offers healthcare-grade hardware solutions that are used by 14 of the top 20 hospitals on the U.S. News & World Report 2022-2023 "Best Hospitals" honor roll. Vizzia has joined the Zebra PartnerConnect program and added its Bluetooth Low Energy (BLE) devices.

* ElectrifAi is a global leader in machine learning (ML) and artificial intelligence (AI) and its Inventory Optimization module generates predictive PAR levels of critical hospital equipment. Vizzia has piloted ElectrifAi at a 500-bed hospital, which yielded a 52% improvement in key metrics.

* Sonicu is an IoT provider of critical environmental monitoring solutions, trusted by more than 500 healthcare customers in all 50 states to meet CDC and Joint Commission compliance. Vizzia has verified the Sonicu technology at the Vizzia IoT Lab onsite at the University of New Mexico.

* HCI provides digital patient engagement solutions to transform the patient experience and streamline caregiver workflows for more than 900 hospitals and 1,500 clinics in all 50 states. Vizzia clients have requested integration with patient communication systems to include Digital Whiteboards.

Meet Vizzia executives and partners at HIMSS Georgia annual conference in Atlanta (Oct. 3) and MD Expo Fall conference in Orlando (Oct. 29-30). Please contact us to schedule a meeting: [email protected].

About Vizzia Technologies

Vizzia Technologies delivers real-time location systems (RTLS) and advanced process improvement solutions for healthcare organizations. Its award-winning InVIEW℠ software platform provides real-time, actionable data and process visibility, empowering hospitals to enhance efficiencies and patient care. With extensive experience serving leading health systems, and industry recognition as a top healthcare technology company, Vizzia produces meaningful results for its hospital customers - lowering costs, increasing productivity and improving care. 

Vizzia received the Frost & Sullivan 2023 RTLS Company of the Year Award, in recognition of its best practices in innovation, performance and unmatched customer care. Visit the Website and follow LinkedIn for more information.

Media Contact: (855) 849-9421, [email protected]

Contact Information:
Jim Forbes
Chief Strategy Officer
[email protected]
+1-855-849-9421


Original Source: Vizzia Technologies Expands New Healthcare RTLS Partnerships & Solutions

Following a successful launch, Space Tea and Sprouts are committed to providing customers with adaptogenic mushroom drinks that contain healthy ingredients, including Reishi mushrooms and Lion's Mane mushrooms, in an amazing-tasting beverage.

LOS ANGELES, July 11, 2023 (Newswire.com) - Space Tea's partnership with Sprouts Farmers Market will now include a prominent placement in chain-wide distribution beginning in July with the launch of iced tea and lemonade beverages, such as best-selling flavor Golden Mango, as well as Original and Watermelon flavors.   

"We are very excited about the national launch of Space Tea inside the beverage aisle at Sprouts," Gabriel Heymann, co-founder and CEO, said. "Their focus on natural, better-for-you products is central to why we created Space Tea."  

After a successful initial trial run in Sprouts, the new launch is a permanent partnership that will feature Space Tea, the world's first adaptogenic mushroom iced tea and lemonade beverage, in the grocery chain's tea/beverage aisle centerpiece, displaying the Original, Golden Mango, and Watermelon flavors. 

"Sprouts was our first national retail partnership and has proven to be a great match with what we provide, a refreshing blend of iced tea and lemonade, and what the store offers in terms of healthy options for the consumer," Heymann said. "We are transitioning to a more permanent location within Sprouts as we evolve our partnership."  

As one of the fastest-growing retailers in the U.S., Sprouts is an ideal location for Space Tea's certified organic, non-GMO, gluten-free, and kosher products, which uses a blend of non-psychoactive, functional Reishi and Lion's Mane mushrooms for enhanced uplifting energy, focus, mood-boosting properties, and mental clarity.  

According to Research and Markets, the global functional beverage market is expected to reach $208 billion in 2027 due to the growing popularity of functional mushrooms found in a variety of healthcare and pharmaceutical products.   

"Space Tea offers high-quality ingredients that have been used for centuries to promote focus and mental clarity," Heymann said. "Sprouts is our latest expansion that enables more people to experience the potential benefits of Reishi and Lion's Mane mushroom in an amazing-tasting beverage format."  

According to tamimteas.com, functional mushrooms with Lion's Mane, Reishi, and Chaga have been used as natural remedies to soothe the body for centuries, supporting digestion, energy, the immune system, mental clarity, mood, relaxation, and sleep. Adaptogens are herbs that can help the body's stress response systems and improve the ability to adapt and restore after stress exposure.

Since its launch in August 2021, Space Tea has quickly become a bestseller of iced tea and lemonade beverages across Southern California and is also available at Bristol Farms, Earthbar, Erewhon Market, Lazy Acres, Mother's Market, and Sun Life.   

To learn more about Space Tea, visit spacetea.com or Instagram at instagram.com/spacetea. Contact Space Tea via email at [email protected].

About Space Tea

Space Tea is the world's first mushroom tea and lemonade featuring a refreshing and classic blend of iced tea and lemonade. Its mission is mental wellness through music, meditation, and mushrooms. Space Tea is brewed with functional, adaptogenic Reishi mushrooms and Lion's Mane mushrooms, which have been studied extensively for their effects on energy, focus, and memory. Check out Space Tea on Instagram at instagram.com/spacetea.    

About Sprouts Farmers Market, Inc.

True to its farm-stand heritage, Sprouts offers a unique grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspires wellness naturally with a carefully curated assortment of better-for-you products paired with purpose-driven people. The healthy grocer continues to bring the latest in wholesome, innovative products made with lifestyle-friendly ingredients such as organic, plant-based and gluten-free. Headquartered in Phoenix and one of the largest and fastest growing specialty retailers of fresh, natural and organic food in the United States, Sprouts employs approximately 31,000 team members and operates more than 380 stores in 23 states nationwide. To learn more about Sprouts, and the good it brings communities, visit about.sprouts.com.

Contact Information:
Maria Penaloza
[email protected]


Original Source: Space Tea and Sprouts Farmers Market Deepen Their Partnership With Long-Term Product Placement

WILMINGTON, Del., July 11, 2023 (Newswire.com) -  A survey of 550 people in the United States with a chronic disease, conducted by Saluto Institute, revealed that 84% of respondents have never worked with a health coach, and 71% are not familiar with how health coaching may benefit them.

Over the past three years, a surge of peer-reviewed research has demonstrated the effectiveness of health coaching for many of the 6 in 10 adults in America who have at least one of the most common (and costly) chronic diseases. Health coaching can benefit patients with cardiovascular disease, high cholesterol, hypertension, diabetes, chronic pain, mental illness, addiction, autoimmune diseases, Alzheimer's disease, and even certain types of cancers. In early 2023, UnitedHealthcare announced the launch of a virtual coaching program for eligible members. In April, Walgreens rolled out a new care coaching program in select pharmacies across seven states. Numerous digital healthcare startups, digital therapeutics providers, and specialty medical practices are hiring health coaches to improve patient care and maximize patient outcomes.

"Health coaches have the potential to play an integral role in solving the community and public health crisis in America," says Lara Zakaria, VP of science education and learner experience at Saluto Institute. Health coaches provide patients with guidance in navigating the healthcare system, create relevant and culturally-responsive health education, offer community care and social support, and develop personalized health behavior modification plans that physicians and other providers don't have the capacity to offer their patients. "Patients who are members of marginalized communities already struggle to access culturally appropriate and inclusive health and wellness resources, and health coaches can change that" affirms Ebony Williams, VP of health equity & inclusion at Saluto Institute.

Even though the United States Bureau of Labor Statistics does not yet include health coaches in its Occupational Outlook Handbook, health coaching is a rapidly growing and future-proof profession that is still, in many ways, in its infancy. Health coaches have a vast array of opportunities to work in various community and clinical settings, and even remotely. Certified health and community wellness coaches learn evidence-informed skills to help people with any number of health conditions. "Connecting people in your community with the resources they need to improve their health is incredibly gratifying and meaningful work," says Saluto Institute's Director of Community Care, advisor, and health coach, Angie Alt.

In August 2023, Saluto Institute will be the first public benefit company to launch a health and community wellness coach certification program. "This program is specifically developed to equip the new generation of health and community wellness coaches with the skills and confidence they need to support, educate and empower their communities, as well as advocate for systemic change," says Zakaria. Saluto Institute will partner with other organizations to continue researching health coaching and its potential implications for patients, healthcare providers, public health systems, health equity, and community wellness.

Contact Information:
Melissa Ackhurst
[email protected]


Original Source: New Study Reveals 84% of Americans With a Chronic Disease Have Never Worked With a Health Coach

The Parkinson's disease market is expected to grow to $12.8 billion by 2028.

LAS VEGAS, July 11, 2023 (Newswire.com) - Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired biopharmaceutical research and development company, has successfully completed a dose response study in rodents at the University of Lethbridge that supports Gb Sciences' cannabinoid-based therapy for Parkinson's disease. The study has established dose ranges and the corresponding times to onset and duration of action in a rodent model. In addition to the dosage range findings, this study demonstrated that Gb Sciences' Parkinson's disease formulations were well tolerated, and there were no adverse effects. As early as next year, Gb Sciences plans on filing an Investigational New Drug Application to begin first-in-human clinical trials. As the second most common neurodegenerative disease, the market for Parkinson's disease (PD) treatments is expected to grow to $12.8 billion by 2028.

"Gb Sciences is developing a first-in-class, cannabinoid-based treatment for the motor symptoms of Parkinson's disease. From this critical study, we have established ranges for the dosage and duration of action in a rodent model that helps us to predict the corresponding and appropriate dose range and duration of action of Gb Sciences' Parkinson's disease therapies for our first-in-human trial," explained Dr. Andrea Small-Howard, President, Chief Science Officer, and board member of Gb Sciences, Inc. "Additionally, this study augments our safety data and suggests that our novel therapeutic may also help alleviate the significant non-motor symptoms of the disease such as problems with sleeping and appetite." 

The dose response study in rodents performed at the University of Lethbridge helps to establish the correct dosing of Gb Sciences' cannabinoid-containing Parkinson's formulations for a first-in-human trial. Dr. Robert Sutherland, Ph.D., FRSC, Professor and Chair of the Department of Neuroscience at the University of Lethbridge, Board of Governors Research Chair in Neuroscience, and Director of the Canadian Centre for Behavioral Neuroscience, used deep learning models to analyze the rich data sets from their "Home Cage Small World" behavioral assessments of rodents with video cameras and Artificial Intelligence, using a system developed by Neurocage Systems Ltd. Future studies confirming the mechanism of action of these cannabinoid-based Parkinson's formulations are planned with Dr. Sutherland's research group at the University of Lethbridge using their state-of-the-art behavioral measurement methods for rodents.

To learn more about Gb Sciences, visit www.gbsciences.com.

About Gb Sciences and GbS Global Biopharma

Gb Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The 'plant-inspired' active ingredients in its therapeutic mixtures are synthetic homologues identical to the original plant compounds but produced under current Good Manufacturing Practices. Gb Sciences' intellectual property portfolio contains six U.S. and five foreign patents issued, 1 U.S. and 3 foreign patents allowed; as well as 18 U.S. and 55 foreign patent-pending applications. In its drug development pipeline, Gb Sciences has five preclinical phase product development programs. Gb Sciences' lead program for Parkinson's disease is being prepared for a first-in-human clinical trial. Gb Sciences' formulations for chronic pain, anxiety and depression are currently in preclinical animal studies with researchers at the National Research Council of Canada (NRC). The company received positive preclinical proof-of-concept data supporting its complex mixtures for the treatment of Cytokine Release Syndrome, and its lead candidates will be optimized based on late-stage preclinical studies at Michigan State University. The Company has also received positive preclinical proof-of-concept data supporting its phytochemical mixtures for the treatment of anxiety. Gb Sciences' productive research and development network includes distinguished universities, hospitals, and Contract Research Organizations. To learn more, visit www.gbsciences.com.

About the University of Lethbridge

Founded in 1967, on traditional Blackfoot land, the University of Lethbridge is home to approximately 8,000 undergraduate and graduate students from around the world. With campuses in Lethbridge and Calgary, ULethbridge is one of Canada's top universities and leading research institutions. Its Blackfoot name, gifted by Elder Bruce Wolf Child, is Iniskim, meaning Sacred Buffalo Stone. The University of Lethbridge is a board-governed public post-secondary institution operating in Alberta as a comprehensive academic and research university under the authority of the Post-secondary Learning Act.

ULethbridge serves the people of southern Alberta through programs, research and creative activity that contribute to economic and social prosperity locally and globally. Founded on the principles of liberal education, the University of Lethbridge is broad in scope while promoting excellence in undergraduate and graduate education that prepares students to understand and address an increasingly complex and interconnected world. The University fosters a learning community that meets the educational and personal growth needs of its students by emphasizing teaching excellence, exposure to research, information literacy, interaction with professors and instructors, effective academic advising, applied learning opportunities and career counseling, as well as a spectrum of cultural, recreational and extracurricular opportunities. To learn more, visit www.ulethbridge.ca.

Forward-Looking Statements

This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company's belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company's business and financial and other results, are contained in the Company's filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Contact Information:
Alexis Quintal
[email protected]


Original Source: Gb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of Lethbridge

As Surgeon General advisory reports teens' use skyrocketing and hurting their development, leader in online mental health diagnosis broadens its efforts.

GRAND RAPIDS, Mich., July 11, 2023 (Newswire.com) - About 95% of American teens report using a social media platform, with more than a third saying they use it "almost constantly." Studies show social media use may affect young people's brain development and make them less happy as teenagers—prompting the U.S. Surgeon General in May to issue a public health advisory on social media use. Mentavi Health has added a validated assessment tool for measuring problematic social media use to its standard ADHD Online assessment process. 

Mentavi Health is the parent company of ADHD Online, the industry leader in virtual ADHD assessment and patient care plans. ADHD Online offers HIPAA-secured ADHD assessments online with certified results from licensed psychologists in all 50 states. 

The Bergen Social Media Addiction Scale (BSMAS), a six-item questionnaire, is a validated assessment tool used in large- and small-scale medical studies. Mentavi Health added the BSMAS at the recommendation of new Chief Medical Officer Dr. Barry K. Herman to help patients and others raise their awareness of their habits related to social media.

Herman said the Surgeon General's Advisory was a wake-up call, informing people that they need to pay more attention to the detrimental effects of social media.

"The Surgeon General's report underscored that urgent action is needed to understand and minimize harm, creating safer online environments for young people. Our team embraced this need and has fully integrated the Bergen Social Media Addiction Scale into our standard ADHD Online assessment process," Herman said.

"Although social media addiction does not yet have a formal diagnosis in the industry, our ADHD assessment will now also provide pertinent information on patient tendencies and risks in these areas, in keeping with our philosophy of providing optimal self-awareness," he said.

The Surgeon General's report notes that harmful effects of social media addiction include increased anxiety, depression, poor concentration, impaired academic and work performance, and decreased overall satisfaction with life. "This is a growing concern among people of all ages, in an area where many have little insight into their behaviors and where consequences can be significant," Herman said.  

Among the findings in the report, which draws on more than 100 studies from pediatricians, psychologists and other experts: 

Children and young adults spend an average of three hours per day on social media platforms.

Social media is designed to be addictive, with features like endless scrolling and notifications that grab attention. 

The appeal of social media is linked to innate social instincts and the release of dopamine in the brain, which can lead to habit formation and addiction.

Harmful effects of social media addiction include increased anxiety and depression, disrupted sleep, inability to concentrate, poor academic and work performance, and less overall satisfaction with life

Risk factors for social media addiction include poor emotion regulation, low self-esteem, and limited coping skills.

In addition to preventive measures like digital detoxes and reducing social media usage, treatment for social media addiction may involve various approaches, such as therapy, counseling, support groups, and addressing underlying mental health issues. 

Mentavi Health believes ADHD Online's ability to assess people's problematic social media use can be a valuable addition to its mission of making better mental and emotional health available to all, regardless of location or physical access to healthcare professionals. 

"We hope that with the addition of the BSMAS, we will be able to help even more people develop a better understanding of their overall mental health and to assist our licensed professionals to diagnose, care and connect people with the treatment they need and deserve," said Herman.

For more information, please visit https://adhdonline.com.

About ADHD Online  

ADHD Online was founded in 2018 with the mission that everyone should have access to quality ADHD assessments regardless of who and where they are. The ADHD Online team is filled with industry experts across the United States who all share the same passion for ADHD and making sure patients have access to critical mental health services. ADHD Online is leading the way with being a critical voice for those who might be struggling with ADHD and is the only organization to offer HIPAA-secured ADHD assessments online with certified results from licensed psychologists. ADHD Online is active in all 50 states. 

Contact Information:
Mike Albanese
[email protected]
Related Images


Original Source: ADHD Online Adds Social Media Addiction Assessment to Its Online Diagnostic Platform